UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 290

Sortiert nach

Multiple myeloma bone disease: pathophysiology of osteoblast inhibition

Blood, 2006-12, Vol.108 (13), p.3992-3996

2006

Link zum Volltext

Verfügbarkeit prüfen

Genetic-based design of a tetra-band high-efficiency radio-frequency energy harvesting system

IET microwaves, antennas & propagation, 2013-12, Vol.7 (15), p.1254-1263

2013

Link zum Volltext

Verfügbarkeit prüfen

Diabetes impairs hematopoietic stem cell mobilization by altering niche function

Science translational medicine, 2011-10, Vol.3 (104), p.104ra101

2011

Link zum Volltext

Verfügbarkeit prüfen

The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients

Blood, 2007-07, Vol.110 (1), p.334-338

2007

Link zum Volltext

Verfügbarkeit prüfen

Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation

Blood, 2005-10, Vol.106 (7), p.2472-2483

2005

Link zum Volltext

Verfügbarkeit prüfen

The p53 Family Protein p73 Provides New Insights into Cancer Chemosensitivity and Targeting

Clinical cancer research, 2009-11, Vol.15 (21), p.6495-6502

2009

Link zum Volltext

Verfügbarkeit prüfen

Production of wnt inhibitors by myeloma cells : Potential effects on canonical wnt pathway in the bone microenvironment

Cancer research (Chicago, Ill.), 2007-08, Vol.67 (16), p.7665-7674

2007

Link zum Volltext

Verfügbarkeit prüfen

IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma

Blood, 2005-08, Vol.106 (4), p.1407-1414

2005

Link zum Volltext

Verfügbarkeit prüfen

Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways

Blood, 2008-09, Vol.112 (6), p.2450-2462

2008

Link zum Volltext

Verfügbarkeit prüfen

Myeloma cells and bone marrow osteoblast interactions: Role in the development of osteolytic lesions in multiple myeloma

Leukemia & lymphoma, 2007-01, Vol.48 (12), p.2323-2329

2007

Link zum Volltext

Verfügbarkeit prüfen

Smart Wireless Power Transfer Operated by Time-Modulated Arrays via a Two-Step Procedure

International journal of antennas and propagation, 2015-01, Vol.2015, p.1-11

2015

Link zum Volltext

Verfügbarkeit prüfen

Time-Modulation of Linear Arrays for Real-Time Reconfigurable Wireless Power Transmission

IEEE transactions on microwave theory and techniques, 2016-02, Vol.64 (2), p.331-342

2016

Link zum Volltext
IEEE_Xplore

MDR1 polymorphism influences the outcome of multiple myeloma patients

British journal of haematology, 2007-06, Vol.137 (5), p.454-456

2007

Link zum Volltext

Verfügbarkeit prüfen

A New Wireless Displacement Sensor Based on Reverse Design of Microwave and Millimeter-Wave Antenna Array

IEEE sensors journal, 2009-11, Vol.9 (11), p.1557-1566

2009

Link zum Volltext
IEEE_Xplore

RF/baseband co-design of switching receivers for multiband microwave energy harvesting

Sensors and actuators. A. Physical., 2012-06, Vol.179, p.158-168

2012

Link zum Volltext

Verfügbarkeit prüfen

Osteogenic differentiation of mesenchymal stem cells in multiple myeloma: Identification of potential therapeutic targets

Experimental hematology, 2009-08, Vol.37 (8), p.879-886

2009

Link zum Volltext

Verfügbarkeit prüfen

Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules

Experimental hematology, 2013-04, Vol.41 (4), p.387-397.e1

2013

Link zum Volltext

Verfügbarkeit prüfen

System-Oriented Harmonic-Balance Algorithms for Circuit-Level Simulation

IEEE transactions on computer-aided design of integrated circuits and systems, 2011-02, Vol.30 (2), p.256-269

2011

Link zum Volltext
IEEE_Xplore

New insight in the mechanism of osteoclast activation and formation in multiple myeloma: focus on the receptor activator of NF-κB ligand (RANKL)

Experimental hematology, 2004-08, Vol.32 (8), p.685-691

2004

Link zum Volltext

Verfügbarkeit prüfen

CC-chemokine ligand 20/macrophage inflammatory protein-3α and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions

Cancer research (Chicago, Ill.), 2008-08, Vol.68 (16), p.6840-6850

2008

Link zum Volltext

Verfügbarkeit prüfen

Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study

The Lancet. Haematology, 2020-12, Vol.7 (12), p.e861-e873

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 290

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(185)
Mit Volltextzugriff
(228)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(156)
Technology
(83)
Engineering
(80)
Engineering, Electrical & Electronic
(79)
Humans
(76)
Life Sciences & Biomedicine
(67)
Hematology
(51)
Circuit Simulation
(42)
Harmonic Analysis
(41)
Microwave Circuits
(41)
Nonlinear Circuits
(36)
Biological And Medical Sciences
(33)
Female
(33)
Middle Aged
(32)
Radio Frequency
(31)
Male
(30)
Medical Sciences
(30)
Physical Sciences
(29)
Microwave Theory And Techniques
(26)
Adult
(25)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multiple myeloma bone disease: pathophysiology of osteoblast inhibition

Genetic-based design of a tetra-band high-efficiency radio-frequency energy harvesting system

Diabetes impairs hematopoietic stem cell mobilization by altering niche function

The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients

Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation

The p53 Family Protein p73 Provides New Insights into Cancer Chemosensitivity and Targeting

Production of wnt inhibitors by myeloma cells : Potential effects on canonical wnt pathway in the bone microenvironment

IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma

Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways

Myeloma cells and bone marrow osteoblast interactions: Role in the development of osteolytic lesions in multiple myeloma

Smart Wireless Power Transfer Operated by Time-Modulated Arrays via a Two-Step Procedure

Time-Modulation of Linear Arrays for Real-Time Reconfigurable Wireless Power Transmission

MDR1 polymorphism influences the outcome of multiple myeloma patients

A New Wireless Displacement Sensor Based on Reverse Design of Microwave and Millimeter-Wave Antenna Array

Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis

RF/baseband co-design of switching receivers for multiband microwave energy harvesting

Osteogenic differentiation of mesenchymal stem cells in multiple myeloma: Identification of potential therapeutic targets

Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules

Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis

System-Oriented Harmonic-Balance Algorithms for Circuit-Level Simulation

New insight in the mechanism of osteoclast activation and formation in multiple myeloma: focus on the receptor activator of NF-κB ligand (RANKL)

Timing for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Chronic Myelomonocytic Leukemia (CMML): A Joint Study from the International MDS/MPN Working Group and the Chronic Malignancies Working Party of the EBMT

The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 α (HIF-1α) activity: involvement in myeloma-induced angiogenesis

CC-chemokine ligand 20/macrophage inflammatory protein-3α and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions

Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study

Suchergebnisse filtern